Explore the complexities of Ulcerative Colitis, its causes, diagnostic methods, and breakthrough treatments for better ...

J&J’s guselkumab gets EU approval for ulcerative colitis, offering new hope for patients who don’t respond to current ...

Ulcerative colitis is a chronic relapsing and remitting inflammatory disorder that can generally be managed successfully with maintenance oral medications. However, approximately 15% of patients ...

Following the study, the FDA approved the use of Tremfya to treat moderately to severely active ulcerative colitis. In September 2024, the University of Chicago Medicine became the first hospital in ...

Ulcerative colitis (UC) is a chronic, long-term medical condition. It's a type of inflammatory bowel disease (IBD). UC can cause inflammation and ulcers in the lining of your colon (large ...

“Other indications that have been reported for fecal transplant have been inflammatory bowel disease — that's Crohn's disease and ulcerative colitis,” says Runa Watkins, MD, an associate ...

“These results are very promising, and we fully endorse the further development of this exciting new oral compound both in ulcerative colitis as well as in other inflammatory diseases including ...

The overlap of biologics during medication switches is common in routine care of patients with IBD and isn’t linked to a ...

Sometimes called fulminant colitis, this complication affects less than 10 percent of people with ulcerative colitis and involves damage to the entire thickness of the intestinal wall.

Ulcerative colitis is an inflammatory bowel disease that is characterized by chronic inflammation of the colon. The direct cause of the disease is unknown, but patients are commonly treated with ...

According to the National Institutes of Health, between 600,000 and 900,000 Americans have ulcerative colitis, a chronic ...